A substantive update of a systematic review of the use of sucrose for analgesia for newborn infants undergoing painful procedures was published recently. 1 The update included 44 randomized controlled trials (RCTs) and 3496 infants, which represented 23 more trials and 1880 more infants than the version published 6 years previously. 2 Key conclusions drawn in 2010 were the same as those drawn in 2004, that sucrose is safe and effective for reducing procedural pain from single events for newborn infants. Even before 2004, recommendations were made that there was sufficient evidence of analgesic benefits of sucrose to implement this intervention for single painful procedures for neonates. 3 In 2001, the International EvidenceBased Group for Neonatal Pain published a consensus statement on the prevention and management of pain in newborns. 4 Sucrose with nonnutritive sucking during painful procedures was 1 of 5 recommendations for practice, with 22 supporting references. Similarly, guidelines released by national and international groups near this time included recommendations to administer sucrose orally during acute painful procedures. [5] [6] [7] Despite such high-quality, synthesized evidence, trials examining the efficacy of sucrose or other sweet solutions for infants during commonly performed painful procedures continue to be published. 1, 8 This continuation of conduct of trials including placebo or notreatment groups potentially contravenes the principal of equipoise. 9 Therefore, the aims of this study were to map the number and nature of publications relating to the use of sucrose or alternative sweet solutions for management of procedural pain in infants, to determine whether and where there is strong evidence, with no further justification for placebo/no treatment groups, and to ascertain where there are knowledge gaps or uncertainties in the evidence. Findings should inform recommendations concerning the ethical basis for conducting additional studies of sweet solutions for procedural pain reduction management in infants.
METHODS
Electronic databases searched included the Cumulative Index to Nursing and Allied Health Literature database , Medline (1950 Medline ( -2009 , Embase (1980 Embase ( -2009 , PsycINFO (1967 PsycINFO ( -2009 , and all evidence-based medicine reviews. The search terms included newborn, infant, neonate, pain, sucrose, glucose, and other terms used to capture alternative sweet solutions, such as lactose, glucose, fructose, glycerine, dextrose, aspartame, polycose, saccharose, and saccharide. No language restrictions were imposed. Reference lists from retrieved articles and personal files also were searched for relevant trials. Articles were excluded if they were duplicates, were subanalyses, or involved animals only or if orally administered sweet solutions were not used. The search concluded as of December 31, 2009.
Data were plotted on a timeline to display graphically the total and cumulative numbers of publications per year from the year of the first identified publication. The method of study; population of participants; type, concentration, and volume of sweet solution used; use of placebo or no-treatment groups and alternative study arms; country where the study was conducted; journals where the study was published; and the language of publication were established.
RESULTS

Publications Identified
A total of 298 unique publications related to analgesic or calming effects of sweet-tasting solutions in human infants were identified. These 298 articles were published in 58 different journals. There were 125 primary efficacy or effectiveness studies (43%), 86 reviews (29%), and 16 systematic reviews (5%) ( Table 1 ). The earliest publication identified, a review of stressreducing effects of milk, sugars, and fats, was published in 1989. 10 The first trial evaluating analgesic effects of sucrose for human infants during painful procedures was published in 1991 by one of the same authors. 11 From 1991, when this first trial was published, to the end of 1997, when the first systematic review of the use of sucrose for pain management in newborn infants was published, 3 an average of 2.7 primary research studies were published each year. After the release of the consensus statement in 2001, 4 the average number of published primary research studies of the use of sucrose or alternative sweet solutions increased to 10 per year. In the 5 years after publication of the 2004 systematic review of the use of sucrose, 2 50 efficacy or effectiveness studies were published, accounting for 40% of the total studies. Of those 50 studies, 42 (84%) included a placebo or no-treatment group, and 30 (60%) of the painful procedures studied were heel lances or venipunctures. In 2008, 14 RCTs were published, which represented the largest number of studies published in a single year (Fig 1) . The cumulative numbers of total publications and primary research studies published each year since 1989 are presented in Fig 2 .
Characteristics of Research Studies
Of the 125 primary research studies evaluating analgesic effects of sweet solutions, 116 (93%) were controlled clinical trials (CCT) or RCTs and 9 (7%) were cohort studies ( 
FIGURE 1
Total numbers of publications related to analgesic effects of sweet solutions each year. 
FIGURE 2
Cumulative numbers of publications per year. Numbers add up to Ͼ125 because 6 studies included Ͼ1 procedure.
Solutions Used
In 74 trials (59%) that used a single sweet solution, sucrose was used, in concentrations ranging from 5.8% to 75%. Glucose, in concentrations ranging from 10% to 50%, was used in 35 studies (28%), and Ͼ1 sweet solution was used in 14 studies (11%). Comparative sweet solutions included alternative concentrations of sucrose or glucose, glycene, fructose, lactose, breast milk, formula milk, and nonsucrose sweetener.
Populations of Infants Studied
More than two-thirds (n ϭ 83 [66%]) of the studies included healthy term or preterm infants. Very low birth weight infants or sick infants in the NICU were included in 22 studies (18%). Nineteen studies (15%) included infants beyond the neonatal period, of which 14 studies were conducted during scheduled childhood immunizations. 19,20,31-42 Analgesic effects of sweet solutions, on the basis of reduced behavioral responses to pain, were reported for 12 (86%) of 14 of those studies; the only 2 with negative results were those in which a 12% sucrose solution was used. 19, 20 Of the remaining 5 studies that included infants beyond the neonatal period, 3 included infants with colic 28-30 and 2 included infants in the emergency department undergoing venipuncture 21 or urethral catheterization. 22 Negative results were obtained for the latter 2 studies, which indicates that administration of a single dose of a sweet solution, 2 minutes before the commencement of painful or distressing procedures, to infants beyond the neonatal period may be insufficient to reduce pain significantly.
Repeated Doses of Sucrose
Ten studies (8%) evaluated the effectiveness of multiple repeated doses of sweet solutions for repeated painful procedures. Seven of those 10 studies were placebo-controlled RCTs, 31,33,43-47 and 3 were cohort studies with no placebo groups. 
Additional Interventions Studied
In addition to either sucrose or glucose, Ͼ1 intervention was evaluated in 74 studies (59%), with most of those (n ϭ 66 [90%]) including a placebo/notreatment group. The number of additional intervention arms ranged from 2 to 9 and included alternative types, concentrations, doses, or delivery methods of sweet solutions; breast or formula milk; eutectic mixture of topical anesthetic; opioid analgesics; breastfeeding; physical interventions such as nonnutritive sucking, facilitated tucking, holding, or kangaroo care; various combinations of interventions; and different methods of either blood collection or circumcision.
In the majority of studies, sucrose or glucose was more effective than small volumes of breast or formula milk or other less-sweet solutions. [52] [53] [54] [55] [56] [57] Kangaroo care 58, 59 and breastfeeding [60] [61] [62] [63] [64] were more or equally effective, compared with sucrose alone, in most studies, with few exceptions. [65] [66] [67] Sucrose or glucose was equal to or more effective than eutectic mixture of topical anesthetics during heel lances, 68 finger pricks, 69 
DISCUSSION
Conclusive evidence from abundant RCTs exists for analgesic effects of sweet solutions, compared with placebo or no treatment, for healthy term and preterm infants in the first month of life during single episodes of heel lancing, venipuncture, or intramuscular injection. Therefore, there is a lack of equipoise, with no ethical justification for conducting additional trials with placebo/no-treatment arms in this population for these frequently performed procedures. As shown by the large number of studies with multiple intervention arms, many investigators are comparing the efficacy of different sweet solutions with other interventions but placebo groups continue to be included. This highlights the fact that, despite the strong body of evidence, sucrose/glucose is not considered standard care.
One explanation for the ongoing conduct of such studies could be the lag time between the commencement of studies and final publication. In the 5 years after publication of the 2004 systematic review of data on the use of sucrose for newborn infants, in which evidence of analgesic effects of sucrose during single episodes of heel lancing or venipuncture was highlighted, 2 50 additional studies were published. Of those, 42 (84%) included a placebo or no-treatment group and 30 (60%) of the painful procedures studied were heel lances or venipunctures, which highlights a continuation of publication of placebo-controlled trials in the presence of lack of equipoise. However, an average delay of 4 to 5 years to publish trials with positive results and 6 to 8 years to publish trials with negative results 89 means that the majority of studies published since 2004 had commenced before the publication of the systematic review, when the analgesic effects of sweet solutions might still have been considered by some to be uncertain. Over the next few years, there should be a reduction in the publication of replicated trials, at least from countries with easy access to health care journals and published synthesized evidence. However, clinicians and researchers in developing countries might have limited access to the same journals and synthesized evidence, which might make it difficult for investigators in such countries to undertake a comprehensive review of the literature. 90 Replication of trials where there is no longer a state of equipoise is therefore a risk. As shown in Table 3 There do remain important knowledge gaps concerning analgesic effects of sweet solutions, and investigators are advised to concentrate on these knowledge gaps in future studies. Such gaps include the efficacy and safety of sweet solutions for extremely preterm infants, the effectiveness of multiple and repeated doses of sweet solutions for sick and preterm infants hospitalized for long periods, the long-term consequences of prolonged use of sweet solutions for management of procedural pain, the effectiveness of sweet solutions for infants receiving concomitant opioid or other strong analgesics, use for procedures of longer duration (such as eye examinations, lumbar punctures, and arterial punctures), and the effectiveness of sweet solutions for infants Ͼ12 months of age.
Although the efficacy and safety of sweet solutions for preterm infants have been well established, only a few studies have included extremely preterm infants at postnatal ages of Ͻ27 weeks. 13,15,43,46, [92] [93] [94] Because infants at such low gestational ages are exposed to numerous painful procedures over months of hospitalization, the consequences of both pain exposure and interventions to reduce pain need to be studied carefully. Only 4 of the 125 studies evaluated repeated doses of sucrose over more than a few days. [44] [45] [46] 49 Ongoing analgesic effects of sucrose were reported in all 4 studies; however, Johnston et al 44, 95 reported worrying findings of poorer neurodevelopmental outcomes for preterm infants who received Ն10 doses of sucrose in the first week of life. Although this finding was not supported in the only other study that evaluated neurodevelopmental outcomes after sucrose use for preterm infants over a longer duration of 1 month, 46 it highlights the dearth of evidence in relation to outcomes other than immediate behavioral and physi-ologic responses after the use of sweet solutions for acute pain.
Another important knowledge gap concerns the effectiveness of sweet solutions in comparison with and given in conjunction with opioid analgesics. Two studies compared glucose with opioid analgesics during a painful procedure 69, 88 and reported conflicting findings; however, the 2 studies were dissimilar in many respects. Axelin et al 88 included preterm infants and Idam-Siuriun et al 69 included term infants in the postoperative period. There also were differences in the choices and doses of opioids used, additional intervention arms, painful procedures, and pain outcomes. These 2 studies highlight uncertainties concerning analgesic effects of sweet solutions for sick infants receiving opioid analgesics. Because current evidence suggests that background infusions of opioid analgesics are ineffective in reducing pain during acute, minor, painful procedures, 96 additional research evaluating effective interventions that can be administered in conjunction with opioid analgesics is warranted.
There is conflicting and insufficient evidence related to analgesic effects of sweet solutions during longer procedures such as eye examinations and urethral catheterizations. Negative findings regarding analgesic effects of sucrose during such procedures might be explained by a lack of sustained effect of a single dose given 2 minutes before commencement of these longer procedures. 97 Although there is now sufficient evidence of benefits of sweet solutions during immunization for infants up to 12 months of age, 97 
CONCLUSIONS
A state of equipoise relating to analgesic benefits of sucrose or glucose in healthy term and preterm infants during single episodes of heel lancing, venipuncture, or intramuscular injection no longer exists. Therefore, it is unethical to conduct additional placebocontrolled or no-treatment trials in this population, and sucrose or glucose should be considered standard care for these procedures in future studies. Uncertainties remain with respect to outcomes after long-term use of sucrose during painful procedures for very preterm and sick infants, effectiveness of concomitantly administered sweet solutions and opioid analgesics, effectiveness during longer procedures, and effectiveness for infants Ͼ12 months of age. Future investigations should focus on addressing these important research gaps regarding sucrose analgesia for our youngest patients. 
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